Author: Chong Lei; Binxiao Su; Hailong Dong; Andrea Bellavia; Raffaele Di Fenza; Bijan Safaee Fakhr; Stefano Gianni; Luigi Giuseppe Grassi; Robert Kacmarek; Caio Cesar Araujo Morais; Riccardo Pinciroli; Emanuele Vassena; Lorenzo Berra
Title: Protocol of a randomized controlled trial testing inhaled Nitric Oxide in mechanically ventilated patients with severe acute respiratory syndrome in COVID-19 (SARS-CoV-2). Document date: 2020_3_13
ID: e99athff_20
Snippet: Patients will be followed until 90 days from enrollment. Secondary outcomes include: (1) time to reach normoxia defined by a PaO2/FiO2> 300 for at least 24 hours during the first 28 days after enrollment. If a patient dies before day 28, the patient will be considered as "never recovered"; (2) proportion of SARS-nCoV-2 free patients (i.e., normoxiemic patients) during the first 28 days after enrollment. If a patient dies before day 28, the patien.....
Document: Patients will be followed until 90 days from enrollment. Secondary outcomes include: (1) time to reach normoxia defined by a PaO2/FiO2> 300 for at least 24 hours during the first 28 days after enrollment. If a patient dies before day 28, the patient will be considered as "never recovered"; (2) proportion of SARS-nCoV-2 free patients (i.e., normoxiemic patients) during the first 28 days after enrollment. If a patient dies before day 28, the patient will be considered as "never recovered"; (3) Survival at 28 days and 90 days from enrollment.
Search related documents:
Co phrase search for related documents, hyperlinks ordered by date